Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$13.7M Buy
79,706
+4,744
+6% +$772K 0.39% 76
2017
Q1
$12.3M Buy
74,962
+4,379
+6% +$728K 0.37% 78
2016
Q4
$10.3M Buy
70,583
+13,461
+24% +$2.03M 0.32% 94
2016
Q3
$9.53M Buy
57,122
+4,468
+8% +$756K 0.3% 91
2016
Q2
$8.01M Sell
52,654
-142
-0.3% -$22.1K 0.27% 99
2016
Q1
$7.92M Sell
52,796
-5,343
-9% -$794K 0.26% 102
2015
Q4
$9.44M Buy
58,139
+1,698
+3% +$267K 0.33% 80
2015
Q3
$7.81M Buy
56,441
+4,070
+8% +$642K 0.25% 105
2015
Q2
$8.04M Buy
52,371
+19,337
+59% +$3.1M 0.25% 101
2015
Q1
$5.28M Sell
33,034
-593
-2% -$93.4K 0.16% 100
2014
Q4
$5.36M Buy
33,627
+1,597
+5% +$249K 0.16% 108
2014
Q3
$4.5M Buy
32,030
+1,755
+6% +$229K 0.04% 112
2014
Q2
$3.58M Buy
30,275
+3,931
+15% +$455K 0.11% 114
2014
Q1
$3.25M Buy
26,344
+1,331
+5% +$161K 0.11% 107
2013
Q4
$2.85M Sell
25,013
-2,647
-10% -$301K 0.1% 119
2013
Q3
$3.1M Buy
27,660
+123
+0.4% +$13.3K 0.12% 137
2013
Q2
$2.72M Buy
+27,537
New +$2.86M 0.1% 145

Other funds holding AMGN

Delta Lloyd's AMGN Position: Q2 2017 in Review

Delta Lloyd increased its Amgen (AMGN) stake by 6.3% in Q2 2017, buying an estimated $772K and bringing the position to 79,706 shares worth $13.7M. The position accounts for 0.39% of the portfolio, ranked #76.

Delta Lloyd first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Delta Lloyd held 79,706 shares of Amgen worth $13.7M as of Q2 2017.
  • Delta Lloyd bought 4,744 Amgen shares in Q2 2017, an estimated $772K.
  • Amgen made up 0.39% of Delta Lloyd's portfolio in Q2 2017, its #76 holding.
  • Delta Lloyd first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.